Search Results
Dec 12, 2025, 01:35 ET Glance Berkolaborasi dengan IAS, Berbagai Fitur Pengukuran Iklan Digital Kini Hadir pada Platform Glance untuk 250 Juta Pengguna di India dan Indonesia
dan Glance akan meluncurkan solusi pengukuran Invalid Traffic (IVT) dan viewability untuk meningkatkan kualitas media periklanan dan performa iklan bagi 250 juta pengguna di India dan Indonesia.Solusi deteksi IVT ikut mengurangi aktivitas anorganik (non-human) atau aksi kecurangan
More news about: Integral Ad Science
Dec 09, 2025, 08:28 ET Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition
diseases. Adverum is evaluating its novel gene therapy candidate, ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022), as a one-time, IVT injection for patients with neovascular or wet age-related macular degeneration. Additionally, by overcoming the challenges associated with current treatment
More news about: Eli Lilly and Company
Dec 03, 2025, 08:30 ET Unlocking mRNA Performance: How Sequence Engineering and GMP Integration Accelerate Therapeutic Success, Upcoming Webinar Hosted by Xtalks
be strengthened through sequence design and GMP-aligned development strategies. Attendees will learn how codon optimization and UTR design influence IVT efficiency, translational output, mRNA stability and manufacturability. The featured speakers will discuss the sequence-level decisions that drive yield,
More news about: Xtalks
Dec 02, 2025, 18:30 ET Brainomix Announces New Study Published in Lancet Digital Health Demonstrating Impact of Brainomix 360 Stroke to Increase Endovascular Thrombectomy Rates
to a specialized center for EVT.A higher rate of intravenous thrombolysis (IVT), a drug treatment for stroke, was observed at evaluation sites, with patients reviewed with AI software more likely to receive IVT (OR 1.99, p<0.0001).The study results support current clinical guidelines
More news about: Brainomix
Nov 25, 2025, 11:57 ET Innova Therapeutics、Enci Therapeuticsの買収により革新的ながん治療の推進へ
Therapeuticsの戦略的買収は、難治性がんに対する治療パラダイムの進展に取り組む当社の揺るぎない姿勢を示すものです」と、Enci Therapeuticsの共同創業者であるNancy Klauber-DeMore氏（医学博士）は述べています。「IVT-8086は、血管新生、腫瘍細胞の成長と生存、免疫機能、転移といった要素を阻害し得る可能性を有しており、こうした極めて困難な疾患と向き合う患者の治療成績を改善するための重要な機会となります。」IVT-8086についてIVT-8086は、分泌型frizzled関連タンパク質2（SFRP2）を阻害することを目的に設計されたヒト化モノクローナル
More news about: Innova Therapeutics
Nov 25, 2025, 10:06 ET Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition
The acquisition of Enci Therapeutics will advance Innova Therapeutics' lead program, IVT-8086, a humanized monoclonal antibody targeting SFRP2 which is expressed in most solid and hematological cancers.IVT-8086 is the only cancer therapeutic that targets multiple cell types associated with
More news about: Innova Therapeutics
Nov 25, 2025, 10:06 ET Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition
acquisition of Enci Therapeutics will advance Innova Therapeutics' lead program, IVT-8086, a humanized monoclonal antibody targeting SFRP2 which is expressed in most solid and hematological cancers.IVT-8086 is the only cancer therapeutic that targets multiple cell types associated
More news about: Innova Therapeutics
Nov 25, 2025, 10:06 ET Innova Therapeutics bringt mit der Übernahme von Enci Therapeutics eine neuartige Krebsbehandlung voran
Enci Therapeutics wird Innova Therapeutics' führendes Programm IVT-8086 voranbringen, einen humanisierten monoklonalen Antikörper, der auf SFRP2 abzielt, das in den meisten soliden und hämatologischen Krebsarten exprimiert wird.IVT-8086 ist das einzige Krebstherapeutikum, das auf mehrere Zelltypen
More news about: Innova Therapeutics
Nov 25, 2025, 10:06 ET Innova Therapeutics impulsará un nuevo tratamiento contra el cáncer con la adquisición de Enci Therapeutics
de Enci Therapeutics impulsará el programa principal de Innova Therapeutics, IVT-8086, un anticuerpo monoclonal humanizado dirigido a SFRP2, que se expresa en la mayoría de los cánceres sólidos y hematológicos.IVT-8086 es el único tratamiento contra el cáncer que se dirige a múltiples tipos
More news about: Innova Therapeutics
Nov 25, 2025, 10:06 ET Innova Therapeutics fait progresser un nouveau traitement contre le cancer grâce à l'acquisition d'Enci Therapeutics
L'acquisition d'Enci Therapeutics fera progresser le programme phare d'Innova Therapeutics, IVT-8086, un anticorps monoclonal humanisé ciblant SFRP2, qui est exprimé dans la plupart des cancers solides et hématologiques.L'IVT-8086 est la seule thérapie anticancéreuse qui cible plusieurs
More news about: Innova Therapeutics
Nov 10, 2025, 03:00 ET Primrose Bio Launches Prima RNApols™ ExTend Cap AU, a Next-Gen RNA Polymerase for Self-Amplifying mRNA
efficiency: Achieves high capping efficiency with less cap, lowering reagent requirements Ultra-low dsRNA: Minimizes unwanted IVT byproducts, reducing downstream purification needs Higher yield of saRNA: Maximizes yield while maintaining integrity and
More news about: Primrose Bio
Nov 05, 2025, 08:35 ET IAS and Snap Announce Expansion of Measurement Partnership to Validate Ad Effectiveness in Sponsored Snaps
Adds Viewability and Invalid Traffic (IVT) Measurement for Chat Feed; Now Enabling IAS Coverage Across all Snapchat Ad Formats on any Device NEW YORK,
More news about: Integral Ad Science (IAS)
Nov 04, 2025, 08:30 ET IAB Tech Lab Launches Device Attestation Support in Open Measurement SDK to Combat Device Spoofing
"Device spoofing is a significant attack vector for bad actors generating invalid traffic across several General and Sophisticated IVT categories required to be detected and filtered as part of MRC Standards," said Ron Pinelli, SVP Digital Research & Standards, MRC. "MRC appreciates
More news about: IAB Tech Lab
Nov 04, 2025, 08:00 ET MCB Real Estate Proposes to Acquire Whitestone REIT for $15.20 Per Share
Urstadt Biddle Properties (5/18/2023), and Kimco Realty acquisition of RPT Realty (8/28/2023).2 Peers defined as AKR, BRX, FRT, IVT, KIM, KRG, PECO, REG and UE.3 S&P Capital IQ Pro. Market Data as of 11/3/2025.4 Peers' implied cap rate per
More news about: MCB Real Estate
Oct 28, 2025, 14:00 ET TikTok Selects IAS for Brand Safety Measurement for TikTok Pangle Advertisers
optimization platform, today announced it was integrated by TikTok Pangle to launch new Brand Safety Features, in addition to Viewability and Invalid Traffic (IVT) Measurement, for advertisers on TikTok Pangle, the TikTok ad network for Business.
More news about: Integral Ad Science, Inc.
Oct 28, 2025, 10:15 ET Cell-free Protein Synthesis Market worth $308.9 million by 2030 with 7.3% CAGR | MarketsandMarkets™
post-translational modifications. By providing specialized systems like the MembraneMax Protein Expression System for membrane proteins and the 1-Step Human Coupled IVT Kit for functional human proteins, Thermo Fisher offers flexibility that few competitors can match. This diversity boosts its market position by enabling
More news about: MarketsandMarkets
Oct 24, 2025, 08:30 ET Lilly to Acquire Adverum Biotechnologies
diseases. Adverum is evaluating its novel gene therapy candidate, ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022), as a one-time, IVT injection for patients with neovascular or wet age-related macular degeneration. Additionally, by overcoming the challenges associated with current treatment
More news about: Eli Lilly and Company
Oct 06, 2025, 08:30 ET Novel Long RNA Manufacturing Approaches for Advancing RNA Therapeutics, Upcoming Webinar Hosted by Xtalks
approaches can drive the development of next-generation RNA medicines. Attendees will understand the limitations of current methods (chemical synthesis and IVT) for long-chain RNA production and the challenges with base modifications. The featured speaker will discuss a novel enzymatic ligation approach using
More news about: Xtalks